# O(6)-Benzylguanine and Carmustine in Treating Patients With Solid Tumors

> **NCT00002604** · PHASE1 · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 28 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** O6-benzylguanine
- **DRUG:** carmustine
- **DRUG:** chemosensitization/potentiation therapy

## Key facts

- **NCT ID:** NCT00002604
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-01
- **Primary completion:** 2000-07
- **Final completion:** 2004-02
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2010-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002604, "O(6)-Benzylguanine and Carmustine in Treating Patients With Solid Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*